Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response PDF $40.00
$40.00
× Placeholder Aripiprazole-Induced Hyperlipidemia: An Update PDF $40.00
$40.00
× Placeholder Chart Review of the Impact of Attention-Deficit/Hyperactivity Disorder Comorbidity on Response to Lithium or Divalproex Sodium in Adolescent Mania PDF $40.00
$40.00
× Placeholder Olanzapine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder PDF $40.00
$40.00
× Placeholder Delirious Mania: An Approach to Diagnosis and Treatment PDF $40.00
$40.00
× Placeholder Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care PDF $40.00
$40.00
× Placeholder Crying But Not Depressed: A Case of Poststroke Emotionalism PDF $40.00
$40.00
× Placeholder Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report PDF $40.00
$40.00
× Placeholder An Open-Label, Flexible-Dose Study of Olanzapine in the Treatment of Trichotillomania PDF $40.00
$40.00
× Placeholder Relation of Serum Anticholinergicity to Cognitive Status in Schizophrenia Patients Taking Clozapine or Risperidone PDF $40.00
$40.00
× Placeholder Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials PDF $40.00
$40.00
× Placeholder What's Next After 50 Years of Psychiatric Drug Development: An FDA Perspective PDF $40.00
$40.00
× Placeholder Resolution of Anxiety Symptoms in Response to Stimulants in a Patient With Attention-Deficit/Hyperactivity Disorder and Generalized Anxiety Disorder PDF $40.00
$40.00
× Placeholder Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Dementia Unspecified: A Multidisciplinary Approach PDF $40.00
$40.00
× Placeholder Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders PDF $40.00
$40.00
× Placeholder Befriending PDF $40.00
$40.00
× Placeholder Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia PDF $40.00
$40.00
× Placeholder Cerebral Venous Thrombosis Following Strangulation PDF $40.00
$40.00
× Placeholder Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies PDF $40.00
$40.00
× Placeholder Successful Readministration of Clozapine in a Patient With a History of Clozapine-Induced Elevation of Creatine Phosphokinase PDF $40.00
$40.00
× Placeholder Tiagabine for Posttraumatic Stress Disorder: A Case Series of 7 Women PDF $40.00
$40.00
× Placeholder Dose-Dependent Bradycardia With Citalopram in an Elderly Patient PDF $40.00
$40.00
× Placeholder The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population PDF $40.00
$40.00
× Placeholder The Role of Consultation-Liaison Psychiatry in the COVID-19 Pandemic PDF $40.00
$40.00
× Placeholder Possible Induction of Mania or Hypomania by Atypical Antipsychotics: An Updated Review of Reported Cases PDF $40.00
$40.00
× Placeholder The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials PDF $40.00
$40.00
× Placeholder Ziprasidone-Induced Ischemic Priapism Requiring Surgical Intervention: A Case Report PDF $40.00
$40.00
× Placeholder Bupropion Extended Release Compared With Escitalopram: Effects on Sexual Functioning and Antidepressant Efficacy in 2 Randomized, Double-Blind, Placebo-Controlled Studies. PDF $40.00
$40.00
× Placeholder Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,200.00
Total $1,200.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe